Does Types of 23S-Ribosomal RNA Point Mutations Affect Eradication Rate in Clarithromycin-Based Triple Therapy?

Does Types of 23S-Ribosomal RNA Point Mutations Affect Eradication Rate in Clarithromycin-Based Triple Therapy?

Saved in:

Bibliographic Details
Main Author:	Da Hyun Jung
Format:	Article
Language:	English
Published:	Korean College of Helicobacter and Upper Gastrointestinal Research 2023-12-01
Series:	The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Online Access:	http://helicojournal.org/upload/pdf/kjhugr-2023-0062.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Types of 23S Ribosomal RNA Point Mutations Affecting Eradication Rates in Clarithromycin-Based Triple Therapy
by: Gihong Park, et al.
Published: (2023-12-01)

Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis
by: Seung Joo Kang, et al.
Published: (2021-03-01)

Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children
by: Yeliz Çağan-Appak, et al.
Published: (2016-08-01)

Helicobacter pylori 23S rRNA gene mutations associated with clarithromycin resistance in chronic gastritis in Vietnam
by: Van Huy Tran, et al.
Published: (2018-07-01)

Mutations of domain V in 23S ribosomal RNA of macrolide-resistant Mycoplasma gallisepticum isolates in Egypt
by: Ahmed M Ammar, et al.
Published: (2016-08-01)

Comparing Two Treatment Regimens for Helicobacter pylori Eradication: Furazolidone or Clarithromycin?
by: Shirin Rezaei, et al.
Published: (2025-07-01)

RNA polymerase I mutant affects ribosomal RNA processing and ribosomal DNA stability
by: Christophe Normand, et al.
Published: (2024-12-01)

Comparative Effectiveness of Levofloxacin-Based Triple Regimen and Standard Clarithromycin-Based Triple Regimen in Eradication of Helicobacter Pylori - Insights from A Peripheral Hospital-Based Study
by: Ijaz Ahmed, et al.
Published: (2025-04-01)

Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
by: Seon Woo Oh, et al.
Published: (2025-03-01)

Comparison of Eradication Rates Using Standard Triple Therapy and Sequential Therapy
by: Yuri Kim, et al.
Published: (2023-12-01)

Estimation of ribosomal RNA transcription rate in situ
by: Chunhua Cui, et al.
Published: (2004-01-01)

A Pilot Study of Helicobacter pylori Eradication Using a Polymerase Chain Reaction-based Test for Clarithromycin Resistance
by: Yun Duk Jung, et al.
Published: (2017-12-01)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
by: Negin Kashani, et al.
Published: (2018-01-01)

Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients
by: Guilherme Felga, et al.
Published: (2010-07-01)

Optimal First-line Eradication Regimens for Helicobacter pylori Infection in Patients with Clarithromycin Resistance: A Pilot Study
by: Min Woo Seo, et al.
Published: (2018-12-01)

In vitro integration of ribosomal RNA synthesis, ribosome assembly, and translation
by: Michael C Jewett, et al.
Published: (2013-06-01)

Clarithromycin crystalluria
by: Zhao Weihua, et al.
Published: (2025-02-01)

Clarithromycin for Children
by: Susan M King
Published: (1995-01-01)

Eradication Rate Using a First-line Triple Therapy for Infection in Yeongdong, Gangwon Province, Korea
by: Eun Jeong Gong, et al.
Published: (2022-06-01)

Helicobacter pylori Eradication Rate in Patients with Diabetes
by: Jiyeon Yoo, et al.
Published: (2017-06-01)

Low dose ribosomal DNA P-loop mutation affects development and enforces autophagy in Arabidopsis
by: Thiruvenkadam Shanmugam, et al.
Published: (2024-12-01)

Clinical Pharmacokinetics of Clarithromycin
by: Marc LeBel
Published: (1993-01-01)

Clarithromycin Resistance Rates of Helicobacter pylori Infected Gastric Biopsies in Korea
by: Moo-Sang CHONG, et al.
Published: (2025-06-01)

Cost-effectiveness of susceptibility-guided therapy under varying rates of clarithromycin resistance
by: Shihan Xu, et al.
Published: (2025-02-01)

Changes in the Eradication Efficacy of Fluoroquinolone-containing Triple Therapy for Infection in Korea
by: Jung Won Lee, et al.
Published: (2020-06-01)

CLARITHROMYCIN IN TREATMENT OF TONSILLITIS IN CHILDREN
by: Yu. L. Soldatskii
Published: (2012-07-01)

Pathophysiology of Antibiotic Resistance: Clarithromycin
by: Diane E Taylor
Published: (2000-01-01)

Microbial Communities as Affected by Clarithromycin Addition in Four Acid Soils (NW Iberian Peninsula)
by: Laura Rodríguez-González, et al.
Published: (2023-04-01)

Can Sequential Therapy Replace Standard Triple Therapy as Eradication?
by: Sang Gyun Kim
Published: (2023-12-01)

Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication
by: Jin Hee Noh, et al.
Published: (2023-09-01)

Ribosomal Proteins in Ribosome Assembly
by: Brigitte Pertschy, et al.
Published: (2024-12-01)

Comparison of Tegoprazan- and Lansoprazole-Based Fourteen-Day Triple Therapies as First-Line Treatments for Eradication
by: Seokin Kang, et al.
Published: (2024-06-01)

Quasispecies Changes with Distinctive Point Mutations in the Hepatitis C Virus Internal Ribosome Entry Site (IRES) Derived from PBMCs and Plasma
by: Luca Mercuri, et al.
Published: (2018-01-01)

RNA mimicry by the fap7 adenylate kinase in ribosome biogenesis.
by: Jérôme Loc'h, et al.
Published: (2014-05-01)

Does time matter? Intraspecific diversity of ribosomal RNA genes in lineages of the allopolyploid model grass Brachypodium hybridum with different evolutionary ages
by: Dana Trunova, et al.
Published: (2024-10-01)

RBIS regulates ribosome biogenesis to affect progression in lung adenocarcinoma
by: Hongyu Pan, et al.
Published: (2024-12-01)

Metabolic RNA Labeling and Translating Ribosome Affinity Purification for Measurement of Nascent RNA Translation
by: Hirotatsu Imai, et al.
Published: (2024-10-01)

The interval of rescue treatment does not affect the efficacy and safety of Helicobacter pylori eradication: A prospective multicenter observational study
by: Minjuan Lin, et al.
Published: (2025-06-01)

Pharmacokinetic Properties of Clarithromycin: A Comparison with Erythromycin and Azithromycin
by: Marc LeBel
Published: (1993-01-01)

Clinical Experience with Clarithromycin for the Treatment of Respiratory Tract Infections
by: Ronald F Grossman
Published: (1993-01-01)